The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hong, Eun Hee | - |
dc.contributor.author | Ahn, Seong Joon | - |
dc.contributor.author | Lim, Han Woong | - |
dc.contributor.author | Lee, Byung Ro | - |
dc.date.accessioned | 2022-07-13T23:35:05Z | - |
dc.date.available | 2022-07-13T23:35:05Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2017-07 | - |
dc.identifier.issn | 1471-2415 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/152058 | - |
dc.description.abstract | Background Hydroxychloroquine (HCQ) retinopathy can accompany other retinal complications such as cystoid macular edema (CME), which leads to central visual loss. We report a case of CME with HCQ retinopathy that improved with the use of oral acetazolamide, and discussed the possible mechanisms of CME in HCQ retinopathy using multimodal imaging modalities. Case presentation A 62-year-old patient with systemic lupus erythematosus (SLE) and HCQ retinopathy developed bilateral CME with visual decline. Fluorescein angiography (FA) showed fluorescein leakage in the macular and midperipheral area. After treatment with oral acetazolamide (250 mg/day) for one month, CME was completely resolved, best corrected visual acuity (BCVA) improved from 20/50 to 20/25, and FA examination showed decreased dye leakage in the macular and midperipheral areas. Conclusions In cases of vision loss in HCQ retinopathy, it is important to consider not only progression of maculopathy, but also development of CME, which can be effectively treated with oral acetazolamide. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | BMC | - |
dc.title | The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ahn, Seong Joon | - |
dc.contributor.affiliatedAuthor | Lim, Han Woong | - |
dc.contributor.affiliatedAuthor | Lee, Byung Ro | - |
dc.identifier.doi | 10.1186/s12886-017-0517-0 | - |
dc.identifier.scopusid | 2-s2.0-85023188912 | - |
dc.identifier.wosid | 000405856600002 | - |
dc.identifier.bibliographicCitation | BMC OPHTHALMOLOGY, v.17, no.1, pp.1 - 5 | - |
dc.relation.isPartOf | BMC OPHTHALMOLOGY | - |
dc.citation.title | BMC OPHTHALMOLOGY | - |
dc.citation.volume | 17 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 5 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Ophthalmology | - |
dc.relation.journalWebOfScienceCategory | Ophthalmology | - |
dc.subject.keywordPlus | CHRONIC INFLAMMATORY REACTION | - |
dc.subject.keywordPlus | BLOOD-RETINA BARRIER | - |
dc.subject.keywordPlus | ACTIVE-TRANSPORT | - |
dc.subject.keywordPlus | CHLOROQUINE RETINOPATHY | - |
dc.subject.keywordPlus | FLUORESCEIN | - |
dc.subject.keywordPlus | PIGMENTOSA | - |
dc.subject.keywordPlus | BREAKDOWN | - |
dc.subject.keywordAuthor | Acetazolamide | - |
dc.subject.keywordAuthor | Case report | - |
dc.subject.keywordAuthor | Cystoid macular edema | - |
dc.subject.keywordAuthor | Hydroxychloroquine retinopathy | - |
dc.identifier.url | https://bmcophthalmol.biomedcentral.com/articles/10.1186/s12886-017-0517-0 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.